David Levitz

743 total citations
44 papers, 402 citations indexed

About

David Levitz is a scholar working on Biomedical Engineering, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Levitz has authored 44 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Biomedical Engineering, 10 papers in Epidemiology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Levitz's work include Optical Coherence Tomography Applications (10 papers), Cervical Cancer and HPV Research (9 papers) and AI in cancer detection (6 papers). David Levitz is often cited by papers focused on Optical Coherence Tomography Applications (10 papers), Cervical Cancer and HPV Research (9 papers) and AI in cancer detection (6 papers). David Levitz collaborates with scholars based in United States, Denmark and Australia. David Levitz's co-authors include Michael H. Frosz, Lars Thrane, Peter E. Andersen, Peter Riis Hansen, Stefan Andersson‐Engels, Steven L. Jacques, Johannes Swartling, Claus B. Andersen, Stephen R. Hanson and Monica T. Hinds and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biomaterials.

In The Last Decade

David Levitz

34 papers receiving 388 citations

Peers

David Levitz
Brady Hunt United States
Noora Neittaanmäki Sweden
Lucas C. Cahill United States
Javiera Pérez‐Ánker Spain
Florence W. Patten United States
Valentin Demidov Canada
Carrie Brookner United States
Volker Jaedicke Germany
Olivier Levecq France
Erika A. Tyburski United States
Brady Hunt United States
David Levitz
Citations per year, relative to David Levitz David Levitz (= 1×) peers Brady Hunt

Countries citing papers authored by David Levitz

Since Specialization
Citations

This map shows the geographic impact of David Levitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Levitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Levitz more than expected).

Fields of papers citing papers by David Levitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Levitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Levitz. The network helps show where David Levitz may publish in the future.

Co-authorship network of co-authors of David Levitz

This figure shows the co-authorship network connecting the top 25 collaborators of David Levitz. A scholar is included among the top collaborators of David Levitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Levitz. David Levitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Levitz, David, et al.. (2024). A Review of Contact Lens Regulations in the Asia Pacific Region. Eye & Contact Lens Science & Clinical Practice. 51(3). e149–e156.
4.
Sanborn, Rachel E., Minal Patel, Jordi Rodón, et al.. (2024). 991O First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors. Annals of Oncology. 35. S675–S676. 1 indexed citations
5.
Mantzaris, Ioannis, Aditi Shastri, Kira Gritsman, et al.. (2024). Metronomic Low-Dose Regimen of Decitabine and Venetoclax Is Safe and Efficacious for Chronic Myelomonocytic Leukemia. Blood. 144(Supplement 1). 6723–6723.
6.
Levitz, David, Yogen Saunthararajah, Lauren Shapiro, et al.. (2023). A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clinical Cancer Research. 29(15). 2774–2780. 10 indexed citations
7.
Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population. Blood. 142(Supplement 1). 2350–2350. 1 indexed citations
8.
Levitz, David, et al.. (2023). AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML. Clinical Lymphoma Myeloma & Leukemia. 23. S282–S283. 1 indexed citations
9.
Sisto, Alex, David Levitz, Ioannis Mantzaris, et al.. (2023). A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx. Blood. 142(Supplement 1). 7397–7397.
10.
Xue, Zhiyun, et al.. (2022). Analysis of digital noise reduction methods on classifiers used in automated visual evaluation. PubMed. 11950. 28–28. 2 indexed citations
11.
Shastri, Aditi, Amit Verma, Eric J. Feldman, et al.. (2022). A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic. Acta Haematologica. 146(2). 144–150. 1 indexed citations
12.
13.
Desai, Kanan, Brian Befano, Zhiyun Xue, et al.. (2021). The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing. International Journal of Cancer. 150(5). 741–752. 44 indexed citations
14.
Levitz, David, et al.. (2016). Real-Time Monitoring and Evaluation of a Visual-Based Cervical Cancer Screening Program Using a Decision Support Job Aid. Diagnostics. 6(2). 20–20. 36 indexed citations
15.
Levitz, David, et al.. (2010). Non-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography. Biomaterials. 31(32). 8210–8217. 16 indexed citations
16.
Levitz, David, Monica T. Hinds, Stephen R. Hanson, & Steven L. Jacques. (2010). Characterizing matrix remodeling in collagen gels using optical coherence tomography. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7554. 75540T–75540T. 1 indexed citations
17.
Jacques, Steven L., et al.. (2008). Measuring tissue optical properties in vivo using reflectance-mode confocal microscopy and OCT. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6864. 68640B–68640B. 15 indexed citations
18.
Thrane, Lars, David Levitz, Michael H. Frosz, et al.. (2004). Characterizing tissue optical properties using optical coherence tomography for diagnostics. 15(12). 21–21. 2 indexed citations
19.
Levitz, David, Claus Andersen, Michael H. Frosz, et al.. (2003). Assessing blood vessel abnormality via extracting scattering properties from OCT images. 5140_12–5140_12. 1 indexed citations
20.
Hansen, Peter Riis, et al.. (2001). Optical coherence tomography. Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brady Hunt Breakdown of academic impact, for papers by Noora Neittaanmäki Breakdown of academic impact, for papers by Lucas C. Cahill Breakdown of academic impact, for papers by Javiera Pérez‐Ánker Breakdown of academic impact, for papers by Florence W. Patten Breakdown of academic impact, for papers by Valentin Demidov Breakdown of academic impact, for papers by Carrie Brookner Breakdown of academic impact, for papers by Volker Jaedicke Breakdown of academic impact, for papers by Olivier Levecq Breakdown of academic impact, for papers by Erika A. Tyburski
Rankless by CCL
2026